http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0035469-A9

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05d3f2c87f77f83168a33803b42d7f1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27155ed29f9b0bfa281f4b21b26d709a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f0100712f1eddf08c70f21abb8faeee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de994cfe7a5a9921a255cbfb101a6b95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f2ad6b4d4081ba2d8724466631ab640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3fc178069da0e70db03acf99dcd2502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
filingDate 1999-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8020387571ba61694c052893a86aa608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee663bbd40a222c0d6f185ec185b6eca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcff0b7b2bf2e834cb1ad2a9ae1a1053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2bcbb83d410d2fe6f3d9081484267ed
publicationDate 2001-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0035469-A9
titleOfInvention hCG THERAPY FOR THE TREATMENT OF BREAST CANCER
abstract This invention relates to the field of cancer therapy. More particularly, the invention relates to the treatment of mammary tumor, clinically manifest mammary tumor (breast cancer) and metastatic mammary tumor by administration of human Chorionic Gonadotropin (hCG). The treatment preferably comprises the administration of hCG in conjunction with an antiestrogen and/or a Type I Interferon.
priorityDate 1998-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100136754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21673
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411198
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05012
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554819
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID473183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9N2J0
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID949
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100052545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130295
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108710621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378525
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID481558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399517
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO77812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410453
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6XZW6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450410796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10444661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1791
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048

Total number of triples: 90.